Comprehensive Analysis Reveals Distinct Immunological and Prognostic Characteristics of CD276/B7-H3 in Pan-Cancer.
Jinye DingYaoqi SunZubaidan SulaimanCaixia LiZhongping ChengShupeng LiuPublished in: International journal of general medicine (2023)
CD276 is a potent biomarker for predicting the prognosis and immunological features in some tumors, and it may play a critical role in the tumor immune microenvironment (TIME) through macrophage-associated signaling.